Latin American flow cytometry market estimated to reach USD 566.5 million by 2022
As per a Grand View Research’s report, the Latin American flow cytometry market is likely to reach USD 566.5 million by 2022. The key factors driving the growth of the market include an expanding target diseases patient base and rising demand for rapid and accurate diagnostic equipment, increasing demand for rapid and precise leukemia prognostic tools, along with rising prevalence rate, research related to drug development, stem cell therapy and in vitro toxicity testing. WHO (World Health Organization) data shows that in 2012, around 603,400 patients were diagnosed with cancer in Latin America, of them 18% were below the age of 75 years. Other therapy areas, which would contribute to the growth of the market, include infectious diseases and immunodeficiency disorders. The bead-based technology is likely to grow at an attractive CAGR of almost 12.0% over the forecast period. Key players of the Latin American flow cytometry market include Life Technologies Corporation, Beckman Coulter, EMD Millipore, Stratedigm, Sysmex Corporation, Miltenyi Biotec, Becton Dickinson and Luminex Corporation.
